Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Exosomes can help promote hair growth and may treat hair loss.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Phototherapy can help treat hair loss in alopecia areata.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Misinformation about alopecia can lead to poor treatment, so it's important for healthcare professionals to correct myths.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Regenerative medicine is effective and safe for treating vitiligo.

Misinformation about alopecia is common online and can harm patient choices.

Alopecia areata significantly impacts patients' mental health and quality of life.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Tretinoin alone is more effective than combined with microdermabrasion for long-term alopecia areata treatment.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.